ß-caryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells.

One of the most common cancers that result in death is lung cancer. There is new hope in the fight against lung cancer thanks to the chemopreventive properties of natural dietary substances like ß-caryophyllene oxide (CPO), and research is currently being done to test this theory. CPO, a sesquiterpene isolated from medicinal plant essential oils, inhibits carcinogenesis and has been effective in treating many cancers. This study examined how CPO affected proliferation of human lung cancer A549 cells. CPO was found to have an inhibitory concentration (IC50) of 124.1 g/ml. The proliferative markers Ki67 and PCNA were significantly inhibited after cells were treated with CPO at a concentration of 50 g/ml compared to controls. CPO-treated cells expressed more P21, P53, and DNA strand breaks than controls. This was accompanied by a significant cell cycle arrest in the S and G2/M phases. In treated A549 cells, this was also associated with a significant induction of apoptosis, as shown by the upregulation of the expression of caspases 3, 7, and 9, as well as Bax, and the downregulation of Bcl-2. Furthermore, the redox status of treated A549 cells revealed a marked rise in GSH and GPx activity levels and a decline in 4-HNE levels, indicating low oxidative stress following CPO treatment of A549 cells. In conclusion, cell cycle arrest and apoptosis, which are unrelated to oxidative stress, were the mechanisms by which CPO reduced cancer lung cell growth. This finding might be a potential therapeutic target for the treatment of lung cancer. Hypothetical scheme of CPO anticancer effects (mechanism of signaling) in A549 cells; in vitro. CPO treatment increases expression of p21, p53 and DNA fragmentation. These events cause arrest of cell cycle which was associated with significant induction in apoptosis via increase expression of caspases (-3,-7,-9), and Bax and downregulation of Bcl-2.

Cactus and lupin extracts as prospective anticancer agents compared with utoral drug.

The ethanolic extracts of many plants have been used in alternative medicine. The present study aimed at evaluating the antioxidant, cytotoxicity, and anticancer potential of cactus and lupin ethanolic extracts compared to utoral drug (UT) on the colon Caco-2 cancer cell line. Bioactive components, cytotoxicity of Caco-2 cell cycle, and gene regulation of apoptosis genes were studied by HPLC, flow cytometer, and RT-PCR, respectively. Lupin extract (LE) contained high bioactive components and antioxidant potential. The predominant phenol, flavonoid, and sterol in LE were rosmarinic acid (2,004.8 µg/ml), quercetin (9,912 µg/g), and ergosterol (2.77 µg/g). LE and its mixture with utoral showed high cytotoxicity and effective potential in regulation of gene expression of proapoptotic and antiapoptotic genes in Caco-2 cells. In conclusion, LE and cactus extract (CE) could be considered as natural preparations with high anticancer properties against Caco-2 cells. LE had the highest anticancer potential among the tested preparations. PRACTICAL APPLICATIONS: The study demonstrated that lupine and cactus extracts have high potential as anticancer substances. These natural extracts can be used to prepare therapeutic mixtures or foods.